“`html
Dyne Therapeutics CEO John Cox purchased 100,000 shares of DYN for $911,000 on Tuesday, buying at $9.11 per share. The stock was trading as low as $8.77 on Wednesday, 3.8% below Cox's purchase price, while it experienced a 7.7% increase on the same day. This marks Cox's second buy in the past year, after previously purchasing shares for $33.04 each.
Helen of Troy’s CEO Brian Grass acquired 10,000 shares for $214,700 at $21.47 each, also on Tuesday. The stock rose by 11.8% on Wednesday.
“`